BUDGET IMPACT ANALYSIS OF LINEZOLID IN THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS IN COLOMBIA

被引：0
|
作者：
Diaz-Sotelo, O. D. [1 ]
Barbosa Castro, T. [2 ]
Ortiz, Vecino A. [3 ]
Vargas Zea, N. [4 ]
Quevedo, Mould J. F. [5 ]
Prieto Martinez, V [4 ,6 ]
机构：
[1] RANDOM Fdn, Bogota, DC, Colombia
[2] RANDOM Fdn, Bogota, Colombia
[3] Johns Hopkins Univ, Baltimore, MD USA
[4] Pfizer SAS, Bogota, Colombia
[5] Pfizer Inc, New York, NY USA
[6] Pfizer Inc, Bogota, Colombia
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.386
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A84 / A84
页数：1
相关论文
共 50 条
  • [41] Impact of linezolid compared with vancomycin on the length of stay of elderly patients with complicated skin and soft-tissue infections due to suspected or proven MRSA
    McCollum, M
    Liu, LZ
    PHARMACOTHERAPY, 2005, 25 (10): : 1460 - 1461
  • [42] Comment: Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections
    Grau, Santiago
    Mateu-de Antonio, Javier
    Marin-Casino, Monica
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (12) : 2280 - 2280
  • [43] Treatment of Skin and Soft Tissue Infections
    Yamamoto, Loren G.
    PEDIATRIC EMERGENCY CARE, 2017, 33 (01) : 49 - 57
  • [44] Impact of complicated skin and soft tissue infections on inpatient costs for an academic medical center
    Patel, N
    Goldfarb, N
    Hartmann, CW
    Maio, V
    Horn, DL
    Pizzi, L
    VALUE IN HEALTH, 2005, 8 (03) : 309 - 309
  • [45] Is linezolid superior to vancomycin for complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus?: Reply
    Weigelt, J
    Itani, K
    Stevens, D
    Knirsch, C
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) : 1910 - 1911
  • [46] Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany
    Dirk Schürmann
    Sonja V. Sorensen
    Erwin De Cock
    Sandeep Duttagupta
    Ansgar Resch
    The European Journal of Health Economics, 2009, 10
  • [47] Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany
    Schuermann, Dirk
    Sorensen, Sonja V.
    De Cock, Erwin
    Duttagupta, Sandeep
    Resch, Ansgar
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2009, 10 (01): : 65 - 79
  • [48] Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue Infections in France
    De Cock, E.
    Sorensen, S.
    Levrat, F.
    Besnier, J. -M.
    Dupon, M.
    Guery, B.
    Duttagupta, S.
    MEDECINE ET MALADIES INFECTIEUSES, 2009, 39 (05): : 330 - 340
  • [49] Linezolid in soft tissue and bone infections
    Kutscha-Lissberg, F
    Hebler, U
    Muhr, G
    Koeller, M
    Schinkel, C
    SHOCK, 2004, 21 : 66 - 66
  • [50] Economic evaluation of treatment for MRSA complicated skin and soft tissue infections in Glasgow hospitals
    R. A. Seaton
    S. Johal
    J. E. Coia
    N. Reid
    S. Cooper
    B. L. Jones
    European Journal of Clinical Microbiology & Infectious Diseases, 2014, 33 : 305 - 311
12345